VEGFA and liver cancer: Both in vitro and in vivo studies have found that 2-ME could reduce the expression of vascular endothelial growth factor (VEGF) and Bcl-2, promote cell cycle arrest and apoptosis of liver cancer cells; the overall effect: inhibition of liver cancer cell proliferation and tumor growth (61).